<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SCD</journal-id><journal-title-group><journal-title>Stem Cell Discovery</journal-title></journal-title-group><issn pub-type="epub">2161-6760</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/scd.2013.32014</article-id><article-id pub-id-type="publisher-id">SCD-29930</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Influence on proliferation and inducing capacity of bone mesenchymal stem cells during myocardial differentiation and construction of engineered myocardium-like tissue &lt;i&gt;in vitro&lt;/i&gt;
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>anhong</surname><given-names>Xing</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lingping</surname><given-names>Tian</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jianhong</surname><given-names>Zhang</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ning</surname><given-names>Wang</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ping</surname><given-names>Chen</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jie</surname><given-names>Ma</given-names></name></contrib></contrib-group><aff id="aff1"><addr-line>Department of Cardiothoracic Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>xwhcardia@sina.com(AX)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>04</month><year>2013</year></pub-date><volume>03</volume><issue>02</issue><fpage>90</fpage><lpage>98</lpage><history><date date-type="received"><day>28</day>	<month>November</month>	<year>2012</year></date><date date-type="rev-recd"><day>31</day>	<month>December</month>	<year>2012</year>	</date><date date-type="accepted"><day>20</day>	<month>January</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   The study is to investigate BMSCs ability to differentiate cardiomyocytes, especially discussed cell generations and 5-Aaz concentration influence on BMSCs capability of proliferation and differentiation into cardiomyocytes during constructing the engineered myocardium-like tissue in vitro. The results have demonstrated that the different concentration of 5-Aza has the influence on proliferation rate of different generations of BMSCs, the second generation BMSCs was superior to the sixth, and tenth generation in proliferation capacity after being induced, and 5-Aza had some influence on proliferation capacity. Rat BMSCs could be differentiated into cardiomyocytes-like cells, which have a good biocompatibility with acellular bovine pericardium, and myocardium-like tissue could be engineered with BMSCs and acellular bovine pericardium in vitro. In conclusion, BMSCs could be induced and differentiated into cardiomyocytes-like cells in vitro. Different generations and different 5-Aza density have influence on the rate of increase of BMSCs, and the engineered myocardium-like tissue could be constructed with BMSCs and acellular bovine pericardium in vitro.
     
 
</p></abstract><kwd-group><kwd>Mesenchymal Stem Cells; Proliferation; 5-Azacitidine; Cardiomyocytes; Myocardium; Tissue Engineering</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>Congenital heart disease (CHD) causes a high morbidity, and maybe one of the leading cause of death for infants, especially neonates [<xref ref-type="bibr" rid="scirp.29930-ref1">1</xref>]. In the last few years, nearly all the cardiovascular congenital malformation could be surgically corrected with the advancement of surgical techniques, monitoring devices and treatments taken after the operation. At present, the repairing materials frequently used in the heart operation are artificial high polymer materials such as polytetrafluoroethylene (ePTFE) and Dacron, which lack contractility and growth potential, and are prone to thrombus formation [<xref ref-type="bibr" rid="scirp.29930-ref2">2</xref>]. In addition, biomaterials like pericardium have the disadvantage of calcification [<xref ref-type="bibr" rid="scirp.29930-ref3">3</xref>]. Because of the disadvantages mentioned above, searching for the ideal materials in CHD surgery has been a hotspot, but cardiac tissue engineering has afforded a new idea and strategy. Mesenchymal stem cells (MSCs) reside in many tissues, especially abundant in bone marrow [4-6]. They have the potential of multi-orientation differentiation in certain conditions. Wakitani and colleagues [<xref ref-type="bibr" rid="scirp.29930-ref7">7</xref>] have confirmed that bone mesenchymal stem cells (BMSCs) could be induced to myocytes by 5-Azacitidine (5-Aza). Tomita and colleagues [<xref ref-type="bibr" rid="scirp.29930-ref8">8</xref>] reported that BMSCs cultured with 5-Aza differentiated into cardiac-like muscle cells in vitro, formed myotubules which stained positively for troponin I and myosin heavy chain, and improved myocardial function in vivo. Xu [<xref ref-type="bibr" rid="scirp.29930-ref9">9</xref>] reported that human MSCs could be induced into cardiomyocytes in vitro by 5-Aza. BMSCs have many advantages such as having no immunogenicity with self source, drawing the materials by bone marrow aspiration with little damage, sufficient sources, and strong expanding capability. Accordingly, MSCs could be one of the ideal resources in cardiac tissue engineering.</p><p>Cardiac tissue engineering aims to construct engineered cardiac tissue with characteristics similar to those of the native tissue. Bioengineered cardiac grafts are created by combining autologous cell transplantation with a degradable scaffold as a temporary extracellular matrix [<xref ref-type="bibr" rid="scirp.29930-ref10">10</xref>]. At present, myocardium-like tissue has been constructed with embryonic stem cells [11,12] or newly born cardiomyocytes [13-15] in vitro, but it is very difficult to practice it clinically for immunologic rejection, ethics and so on. This study discussed cell generation and 5-Aaz concentration influence on BMSCs’ capability of proliferation and differentiation into cardiomyocytes, and attempted to construct the engineered myocardium-like tissue with BMSCs and acellular bovine pericardium in vitro. Our results may provide the step on the long road toward engineered myocardial tissue for repairing the nonfunctional myocardium or defect in CHD, such as ventricular septal defect or tetralogy of Fallot.</p></sec><sec id="s2"><title>2. MATERIALS AND METHODS</title><sec id="s2_1"><title>2.1. Isolation of BMSCs and Myocardial Differentiation</title><p>4 weeks old male Sprague Dawley rats, weighing 100 - 120 grams were provided by the Institutional Experimental Animal Center of Shanxi medical university. Animal treatment corresponded to Management and use of laboratory Guide issued by US National Institutes of Health. The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee.</p><p>Rats were executed by suffocation with carbon dioxide, and were then immersed in 75% alcohol for 5 minutes. Under the condition of no destroying rat thigh bone, two hind legs of the rat were dissected, and the fur, muscle and tendon of the legs were wiped out. Thigh bone was immersed in 75% alcohol for 3 minutes. It was then rinsed 2 times with PBS, and immersed in complete medium-LG-DMEM. The thigh bone was broken, and the marrow cavity was washed repeatedly 3 times with LG-DMEM. Slowly adding washing fluid which was obtained from marrow cavity as has been shown above on the surface of 5 ml Percoll Liquid Separation (1.077 g/ml), the mixture was centrifuged at centrifugal force of 1100 g/min for 30 minutes, and the stratum intermedium of mononuclear cells was sucked. The cells at the density of 2.5 &#215; 10<sup>5 </sup>cells/cm<sup>2</sup> were inoculated in the culture plate which contained 10% Fetal Bovine Serum (FBS) and Low Glucose Dulbecco’s modified Eagle medium (LGDMEM). The cells above were cultured in the incubator which contained 5% CO<sub>2</sub> at 37˚C. Primary passage changed the medium at the fourth day, and then changed the culture medium every 3 days. When the attached cells got near confluence, they were digested by 0.25% pamcreatin-EDTA. The cells were transferred to culture at the ratio of 1:3 when passaged. The cell morphology was observed with Inverted phase contrast microscope (CKX 41, Olympus Company).</p></sec><sec id="s2_2"><title>2.2. BMSCs Proliferation and Growth Curve</title><p>The second generation of BMSCs was digested by 0.25% pamcreatin-EDTA，cell density was adjusted to 3 &#215; 10<sup>4 </sup>cells/ml, and the cells were inoculated in nine 96 well plates. 200 μl of cell suspension was added in each well. Got one of the plates every day after their adherence, and 20 μl MTT (5 mg/ml) was added into every well. The cells were incubated at &#177;37˚C for 4 hours, and supernatant in every well was then discarded. 150 μl DMSO was added into each well, then the plate was placed on the concentrator for 10 minutes at low-speed oscillation in order to dissolve the purple crystal sufficiently. The absorbance (OD) of each well was measured with ELISA apparatus (680, Bio-Rad) at 490 nm wavelength, the results were recorded, and the growth curve was drawn.</p></sec><sec id="s2_3"><title>2.3. Myocardial Differentiation</title><p>When the BMSCs had been passaged for second, sixth, or tenth generation, they were incubated by 5 μmol/L, 10 μmol/L, and 15 μmol/L 5-Aza for 24 hours respectively. The culture medium which contained 5-Aza was sucked. Then they were cultured for 4 weeks. Untreated cells acted as negative control group. Cell morphology were monitored by Inverted phase contrast microscope (CKX41, Olympus Company).</p></sec><sec id="s2_4"><title>2.4. Different Generations of BMSCs and Different 5-Aza Density Influence on Rate of Increase</title><p>BMSCs at the second, sixth, and tenth generation were selected, and were inoculated in a 96 well plate at a cell density of 3 &#215; 10<sup>4</sup> cells/ml respectively. Three plates were inoculated for each generation. Each plate was divided into 4 groups, each group included 23 wells, and the remaining 4 wells were set up for zero holes. Three groups in every 96 well plate acted as induced groups, and 5 μmol/L, 10 μmol/L, 15 μmol/L 5-Aza was used to inoculate BMSCs for 24 hours respectively. 23 wells acted as a control group in every 96 well plate, and were inoculated in complete medium for 24 hours. All groups were then incubated with complete medium for 5 days. Absorbance (OD) was measured with MTT at the first, third and fifth day after being induced with 5-Aza.</p></sec><sec id="s2_5"><title>2.5. Immunocytochemistry for Cardiac Specific Proteins</title><p>BMSCs at the second, sixth and tenth generation were detected with Desmin after being induced with the different concentrations, i.e. 5 μmol/L, 10 μmol/L and 15 μmol/L 5-Aza for 4 weeks. The second generation BMSCs were detected with troponin T, α-Actin expression after being induced with 10 μmol/L 5-Aza for 4 weeks, The normal rat cardiomyocytes acted as a positive control group, and the untreated BMSCs acted as negative control group.</p><p>Cells that grown on labteck chamber slides (50 &#215; 10<sup>4</sup> cells/well) (Nunc) were washed with PBS (0.01 mmol/L, pH 7.4), fixed with 4%<sup> </sup>paraformaldehyde for 20 min and permeabilized with 0.1% Triton X-100/PBS (Sigma) for 15 min. Endogenous peroxidase was blocked with 3% H<sub>2</sub>O<sub>2</sub>—methanol for 15 min. Each manipulation was preceded by washing the cells three times in PBS with 0.05% Tween 20 (Sigma). After blocking in PBS-BSA 5% (Sigma) for 1 h, the cells were incubated overnight at 4˚C with the primary antibodies: Rabbit polyclonal to Desmin (Desmin, crossreactivity with mouse) 1:300, Shanghai Bluegene Biotech CO., LTD; Mouse antiRabbit cardiac Troponin T (cTnT, crossreactivity with mouse), 1:200, Sigma; Rabbit polyclonal to alpha smooth muscle Actin (α-Actin, crossreactivity with mouse), 1:300, Sigma. Bound primary antibodies were visualized by Peroxidase labeled streptomycin avidin staining reagents (Shanghai Bluegene Biotech CO., LTD). Slices were mounted, and were observed with Inverted microscope system (CKX 41, Olympus Company). The same protocols were followed for staining of the normal rat cardiomyocytes and the untreated BMSCs.</p></sec><sec id="s2_6"><title>2.6. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) for Cardiac Specific Genes</title><p>Total RNA was extracted from the second passage BMSCs which have been induced with 5-Aza for 4 weeks using Trizol reagent (Invitrogen, Carlsbad, CA). RNA samples were treated with Superscript III RNase H-reverse transcriptase (Invitrogen, Carlsbad, CA) to converting to cDNA in a 20 μL reaction mixture. The sequences of PCR primers for GATA-4, Nkx 2.5 and TDGF-l were as follows: GATA-4, 130 bp, 5’-GAC TGA GTT CTG GGC ATCT-3’ and 5’-CAA TCT TTA GGC TCT GGTTT-3’; Nkx 2.5, 102 bp, 5’-CGC CAA CAG CAA CTT CGT-3’ and 5’-ATG CCG TGC AGC GTG GAGAC-3’; TDGF-l, 183 bp, 5’-GCA ACT GTG AGC ACG ATG-3’ and 5’-GTG GAG TCC TGG ATA CCTT-3’. RNA of untreated third passage BMSCs was used as negative control. The PCR products were sizefractionated by 1% agarose gel electrophoresis.</p></sec><sec id="s2_7"><title>2.7. Preparation for Acellular Bovine Pericardium Biomaterial</title><p>Fresh adult bovine pericardium was collected and transported in ice brine protection. Residual fat and connective tissue was removed from the pericardial surface. The bovine pericardium was cut into pieces of 0.5 cm &#215; 0.5 cm, put in 0.1% bromogeramine liquid for 30 minutes, then washed repeatedly with PBS to remove bromogeramine from the bovine surface. Acellular bovine pericardium was obtained by using the method of detergent-enzyme digestion [<xref ref-type="bibr" rid="scirp.29930-ref16">16</xref>], and it was crosslinked with 0.625% genipin solution (2 ml/cm<sup>2</sup>) for 72 hours. Then the acellular bovine pericardium was rinsed with PBS. It was placed on a Petri dish, thoroughly disinfected by ultraviolet light for 20 minutes, immersed in 75% alcohol for 30 minutes, and rinsed 3 times with PBS. After this procedure, it was placed in LG-DMEM for 6 hours before seeded by BMSCs.</p></sec><sec id="s2_8"><title>2.8. Construct the Engineered Myocardium-Like Tissue</title><p>After BMSCs at the third generation induced by 10 μmol/L 5-Aza had overgrown the 100 millimeter-sized culture dish, they were digested by 0.25% pancreatinEDTA, then centrifuged with 1500 rpm &#215; 10 min. The supernatant was thrown away and the appropriate amount culture medium was added to form cell suspension. Cells with a density of 4.0 - 5.0 &#215; 10<sup>6</sup> cells/cm<sup>2 </sup>were implanted on acellular bovine pericardium which had been treated with Poly-L-Lysine at a concentration of 2 mg/180 ml. After 4 hours incubation +37˚C, 5% CO<sub>2</sub>, the sufficient cell culture medium was added, supplemented with 10 μmol/L Basic fibroblast growth factor (bFGF). The complex of cells and scaffold had been cultured for 2 weeks in the Incubator +37˚C, 5% CO<sub>2</sub>. During this period, the culture medium was changed every two days. After it had been seeded for 2 weeks, histological detection was made.</p></sec><sec id="s2_9"><title>2.9. Statistical Analysis</title><p>The sample data was analyzed with SPSS 13.0. Data description was indicated with mean &#177; standard deviation (X &#177; SD). The difference among groups was analyzed with Analysis of variance (ANOVA). Comparison between two groups was tested with the student-Newman-Keuls (SNK) method. Test level is α = 0.05, and P &lt; 0.05 is significant difference.</p></sec></sec><sec id="s3"><title>3. RESULTS</title><sec id="s3_1"><title>3.1. BMSCs Isolation, Culture and Morphology Observation</title><p>The BMSCs during the primary culture period looked like small, short spindle or triangular cells after they had been seeded in the complete medium for 48 hours, and the cells had a good refractional capability. The percoll particles could be seen on the surface of the cells. After they had been seeded for 72 hours, the BMSCs looked like slender spindle cells. From the fourth day, the BMSCs had a significant proliferation, companied with many double refraction bodies, and formed island-like clones. Cells were arranged irregularly when cell density was lower, and triangular cells could be seen. Cells formed 70% - 80% confluence at the seventh-tenth day, then began to arrange regularly, and appeared as bundle, whirlpool or fish-like shapes. BMSCs’ morphology tended to be a unanimous appearance when passaged to the second generation (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Some of the cells at every generation died after being induced with 5 μmol/L, 10 μmol/L or 15 μmol/L 5-Aza for 24 hours. Cell mortality was increased with higher 5-Aza concentration, but generations didn’t seem to have an influence on cell mortality. After being induced with 5-Aza for 24 hours, some of the adherent cells became flat or short rod shape. Cells began to proliferate after being induced for 3 days, some presented the slender spindle shape, and others appeared triangular or polygonnal. After being cultured for 4 weeks, 80% - 90% cells presented mainly with a myofiber shape, though a few looked polygonal or flagstone-like shape, and cells grew</p><p>in an aggregation-like method. No spontaneous beating cells could be observed for different generations of BMSCs or different concentrations of 5-Aza (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s3_2"><title>3.2. Rat BMSCs Proliferation and Growth Curve</title><p>BMSCs subculture incubation period continued 1 or 2 days. By the third or fourth day, they had begun the logarithmic growth phase. At the sixth or seventh day, they entered into the platform period (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Different Concentration 5-Aza Influence on Proliferation Rate of Different Generations of BMSCs</title><p>BMSCs at different generations induced with different concentrations of 5-Aza were detected with MTT. It has been demonstrated that the second generation BMSCs was superior to the sixth, and tenth generation in proliferation capacity after being induced, but there was no statistical difference between the sixth and tenth comparison. In the control group, having no induction with 5-Aza, the second and sixth generation BMSCs showed no statistical difference in proliferation capacity, but all were superior to the tenth generation. 5-Aza had some influence on proliferation capacity, but with the increase of generations, this influence had a weakening trend (Figures 4-6 and Tables 1 and 2).</p></sec><sec id="s3_4"><title>3.4. Immunocytochemistry</title><p>BMSCs at the second, sixth and tenth generation were</p><p>detected with immunocytochemistry for Desmin after being induced with the different concentrations, i.e. 5 μmol/L, 10 μmol/L and 15 μmol/L 5-Aza for 4 weeks. Cells in all groups had positive expression for desmin. It was demonstrated that BMSCs at the second, sixth and tenth generation treated with the three different concentrations above had been induced and transformed to the myocardial orientation, and expressed cardiac-specific protein (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><p><xref ref-type="table" rid="table1">Table 1</xref>. The proliferation rate of the second, sixth and tenth BMSCs induced with the concentration 5-Aza for 5 days and control group BMSCs.</p><p><img src="3-1080055\9966a8a7-a673-487e-9549-744abd82bc74.jpg" /></p><p>Note: <sup>*</sup>indicate P &lt; 0.05 when compared with the second generation, <sup>△</sup>indicate P &lt; 0.05 when compared with the 6th generation.</p><p><xref ref-type="table" rid="table2">Table 2</xref>. The proliferation rate of the same passage BMSCs induced with the different concentration 5-Aza for 5 days and control group BMSCs.</p><p><img src="3-1080055\ca83a616-84d0-4ca6-b637-3cc01d05bac8.jpg" /></p><p>Note: <sup>*</sup>indicate P &lt; 0.05 when compared with the control group, <sup>△</sup>indicate P &lt; 0.05 when compared with the group induced with 5 μmol 5-Aza.</p><p>After the second generation BMSCs being induced with 10 μmol/L 5-Aza for 4 weeks, the induced group, negative group and positive group were detected with immunocytochemistry for troponin T, α-Actin expression. BMSCs in the induced group and positive group showed expression, but BMSCs in the negative group had no expression. It was demonstrated that BMSCs treated with 5-Aza have been induced and transformed to the myocardial orientation, and expressed cardiac-specific protein (<xref ref-type="fig" rid="fig8">Figure 8</xref>).</p></sec><sec id="s3_5"><title>3.5. Associated Gene Expression with Reverse Transcription-Polymerase Chain Reaction (RT-PCR)</title><p>The results of RT-PCR indicated that BMSCs induced with 5-Aza expressed GATA-4, Nkx 2.5 and TDGF-l. The induced group had an obvious stripe at 130 pb, 102 pb and 183 pb. It was demonstrated that BMSCs in the induced group had expressed the early myocardial forming transcription factor, such as GATA-4, Nkx 2.5, TDGF-l, etc., but none of in the control group (<xref ref-type="fig" rid="fig9">Figure 9</xref>).</p></sec><sec id="s3_6"><title>3.6. Construction of Myocardium-Like Tissue in Vitro and Observation</title><p>Bovine pericardium after treatment with 0.625% genipin solution presented light blue. Its texture was flexible, and had a highly flexible character (<xref ref-type="fig" rid="fig1">Figure 1</xref>0).</p><p>Induced BMSCs were attached on the surface of bovine pericardium, and the levels were distinctive. It was demonstrated that induced BMSCs could be attached on the surface of acellular bovine pericardium (<xref ref-type="fig" rid="fig1">Figure 1</xref>1).</p></sec></sec><sec id="s4"><title>4. DISCUSSION</title><p>At present, all kinds of repair materials applied during CHD surgery would lack contractility and growth potential, and have the risk of calcification and thrombus-poietic, which often requires repeat operations in the future [<xref ref-type="bibr" rid="scirp.29930-ref17">17</xref>]. In addition, effective treatment of heart failure resulting from ischemic heart disease would have been still a challenge. Unlike other tissues, myocardium has no substitute which could be used to repair myocardial defect or damaged cardiac tissue. With the development of cell culture technology in vitro and the conception of tissue engineering, myocardial regenerative medicine has become an exciting therapy for treatment of myocardial injury [<xref ref-type="bibr" rid="scirp.29930-ref18">18</xref>]. Construction of tissue engineered myocardium in vitro has become a challenging target in cardiovascular tissue engineering following cell transplant.</p><p>It was demonstrated that MSCs, Endothelial Progenitor Cells, Skeletal Myoblasts, Embryonic Stem Cells, etc., could be induced to Myocardial cells in vitro or in vivo [<xref ref-type="bibr" rid="scirp.29930-ref19">19</xref>]. BMSCs are a kind of primitive bone marrow stromal cells, and have properties such as self-renewal, amplification and muti-directional differentiation potentiality. Under certain conditions, they could be differentiated into many kinds of histiocytes [<xref ref-type="bibr" rid="scirp.29930-ref20">20</xref>]. MSCs have become one of the hotspots as seeding cells in cardiac tissue engineering [<xref ref-type="bibr" rid="scirp.29930-ref21">21</xref>]. However, MSCs content in bone marrow is very low. When it is near higher density during the period of cell culture, cells enter into platform, and the morphology converts from a spindle-like form to a bigger, flatter shape [<xref ref-type="bibr" rid="scirp.29930-ref22">22</xref>]. The capability of cell proliferation and differentiation could be influenced. When constructing the engineered cardiac tissue, first of all, we need sufficient cells and their good differentiation capability. Thus, a means of obtaining the sufficient cells and good differentiation capability would be necessary to rationalize MSCs use.</p><p>In this study, we have demonstrated that cell passages had influence on BMSCs quantity, multiplication capacity, differentiation capacity and purity. The multiplication capacity of the second generation was superior to that of the sixth or tenth generation, but no difference occured between the sixth and tenth. In the same generation, such as the second, the sixth and tenth generation, different 5-Aza concentrations had no influence on multiplication capacity. With the increase of cell passages, 5-Aza concentration had a decreasing influence on multiplication capacity. BMSCs induced with 5-Aza expressed cardiac-specific protein. Qian demonstrated that the expression rate of Cardiac-specific protein in tenth generation MSCs was superior to that of the first, fourth or eighth generation after induced with 5-Aza [<xref ref-type="bibr" rid="scirp.29930-ref23">23</xref>]. Therefore, in the case of the same proliferation capability, there is a bigger cell quantity and stronger differentiation capacity with the increase of cell passages. In this study, we tried to use the induced BMSCs of third generation as the seeding cells for constructing myocardium-like tissue in vitro.</p><p>So far, there are several methods to induce MSCs to cardiomyocytes, including a co-culture system to mimic myocardial microenvironment [<xref ref-type="bibr" rid="scirp.29930-ref24">24</xref>], physical stimulation [<xref ref-type="bibr" rid="scirp.29930-ref18">18</xref>], and chemical compound induction. Among these methods, 5-Aza, a chemical compound, has been regarded as an effective agent for inducing differentiation of MSCs into cardiomyocytes in vitro. However, the optimal 5-Aza concentration, MSCs quantity, long-term safety and efficacy of the differentiated MSCs in vivo still need to be studied and further confirmed.</p><p>Scaffold material is another difficult point when constructing the engineered cardiac tissue in vitro [<xref ref-type="bibr" rid="scirp.29930-ref25">25</xref>]. In recent years, it has been found that acellular scaffold material was one kind of bio-derived material which has good properties, with a natural microenvironment and the following advantages [<xref ref-type="bibr" rid="scirp.29930-ref26">26</xref>]: low antigenicity, good biological chemotaxis, involved in tissue healing process, cellular and vascular forming, adjusted degradation time, etc. Chang et al. [<xref ref-type="bibr" rid="scirp.29930-ref27">27</xref>] has demonstrated that acellular bovine pericardium crosslinked with genipin, a natural cross-linking agent, had lesser inflammatory reaction than with the traditional methods when it was implanted in vivo, and it could afford a good natural microenvironment for cell migration and tissue regeneration.</p><p>Bovine pericardium is mainly made of I type collagen, which reaching up to 95%. Bovine pericardium is characterized by good flexibility, little antigenicity, good biocompatibility, etc. MSCs adherence with acellular bovine pericardium scaffolds have two types, non-specific adhesion and specific adhesion. Non-specific adhesion is decided by physical property of bio-material and cell surface. It is called specific adhesion if it is involved in the specific interactions of surface molecules among them. As far as we know, there are 4 types of cell surface adhesion molecules: Cadherin, Integrin, Immunoglobulin superfamily adhesion molecule and Select lectin [<xref ref-type="bibr" rid="scirp.29930-ref28">28</xref>]. It was demonstrated that cell adherence could be increased with scaffolds preloaded with polylysine, bFGF, etc., which promoted cell growth and proliferation also [<xref ref-type="bibr" rid="scirp.29930-ref29">29</xref>].</p><p>In this study, we have discussed BMSCs could be induced and differentiated into cardiomyocytes-like cells via treated with 5-Aza in vitro, and cell generations and 5-Aaz concentration influence on BMSCs’ capability of proliferation and differentiation into cardiomyocytes. We have optimized the method of the cellular seeding on scaffolds. We used third generation BMSCs as the seeding cells, and used the classical 5-Aza induction method, then bFGF in culture media to promote BMSCs differentiation to cardiomyocytes. We seeded induced BMSCs in the static inoculation on the acellular bovine pericardium which had been coated with Poly-L-Lysine when constructing the engineered caidiac tissue in vitro. The experimental method was reliable, and the procedure was simple. Induced BMSCs could express cardiac-specific proteins such as troponin T, α-Actin and Early myocardial transcription factors such as GATA-4, Nkx 2.5, TDGF-l. Furthermore, we have preliminarily confirmed the possibility of constructing the engineered cardiac tissue with adult stem cells and the acellular bovine pericardium in vitro, but still had some limitations such as no cultivation in vivo and no further detection of engineered myocardium-like tissue. However, this study has established the basis for further constructing tissue engineered myocardium and repairing the damaged heart in the future.</p></sec><sec id="s5"><title>5. ACKNOWLEDGEMENTS</title><p>In this study, Wanhong Xing has duty of research design, data analysis and interpretation. Lingping Tian has afforded some concept about the research, and done the Statistics for data. Ning Wang and Jianhong Zhang have done cell culture, differentiation and construction of engineered cardiac tissue in vitro. Ping Chen has done the research of acellular bovine pericardium biomaterial and constructed the engineered cardiac tissue in vitro. Jie Ma has done the Critical revision of this article. Research Project Supported by Shanxi Scholarship Council of China (2012091) and Shanxi Science and Technology Agency, China (20120313021-3) is gratefully acknowledged.</p></sec><sec id="s6"><title>REFERENCES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.29930-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ding, W.-X. (2000) The review and prospect of pediatric heart surgery in China. Chinese Journal of Pediatric Surgery, 21, 266.</mixed-citation></ref><ref id="scirp.29930-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sakai, T., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.T., Jia, Z.Q. and Yau, T.M. (2001) The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. The Journal of Thoracic and Cardiovascular Surgery, 121, 932-942. doi:10.1067/mtc.2001.113600</mixed-citation></ref><ref id="scirp.29930-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mirsadraee, S., Wilcox, H.E., Watterson, K.G., Kearney, J.N., Hunt, J., Fisher, J. and Ingham, E. (2007) Biocompatibility of acellular human pericardium. Journal of Surgical Research, 143, 407-414.  
doi:10.1016/j.jss.2007.01.026</mixed-citation></ref><ref id="scirp.29930-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Young, H.E., Mancini, M.L., Wright, R.P., Smith, J.C., Black Jr., A.C., Reagan, C.R. and Lucas, P.A. (1995) Mesenchymal stem cells reside within the connective tissues of many organs. Developmental Dynamics, 202, 137-144. doi:10.1002/aja.1002020205</mixed-citation></ref><ref id="scirp.29930-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Prockop, D.J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71-74.  
doi:10.1126/science.276.5309.71</mixed-citation></ref><ref id="scirp.29930-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kern, S., Eichler, H., Stoeve, J., Klüter, H. and Bieback, K. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294-1301. 
doi:10.1634/stemcells.2005-0342</mixed-citation></ref><ref id="scirp.29930-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wakitami, S., Saito, T. and Caplan, A.I. (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 18, 1417-1426. doi:10.1002/mus.880181212</mixed-citation></ref><ref id="scirp.29930-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomita</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> Li</surname><given-names> R.K.</given-names></name>,<name name-style="western"><surname> Weisel</surname><given-names> R.D.</given-names></name>,<name name-style="western"><surname> Mickle</surname><given-names> D.A.</given-names></name>,<name name-style="western"><surname> Kim</surname><given-names> E.J.</given-names></name>,<name name-style="western"><surname> Sakai</surname><given-names> T. and Jia</given-names></name>,<name name-style="western"><surname> Z.Q. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1999</year>)<article-title>Autologus transplantation of bone marrow cells improves damaged heart function</article-title><source> Circulation</source><volume> 100</volume>,<fpage> 247</fpage>-<lpage>256</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.29930-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names> W.</given-names></name>,<name name-style="western"><surname> Zhang</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> Qian</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Zhu</surname><given-names> W.</given-names></name>,<name name-style="western"><surname> Sun</surname><given-names> X.</given-names></name>,<name name-style="western"><surname> Hu</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> Zhou</surname><given-names> H. and Chen</given-names></name>,<name name-style="western"><surname> Y. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro</article-title><source> Experimental Biology and Medicine</source><volume> 229</volume>,<fpage> 623</fpage>-<lpage>631</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.29930-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ishii, O., Shin, M., Sueda, T. and Vacanti, J.P. (2005) In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. The Journal of Thoracic and Cardiovascular Surgery, 130, 1358-1363. doi:10.1016/j.jtcvs.2005.05.048</mixed-citation></ref><ref id="scirp.29930-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Guo, X.M., Zhao, Y.S., Chang, H.X., Wang, C.Y., E, L.L., Zhang, X.A., Duan, C.M., Dong, L.Z., Jiang, H., Li, J., Song, Y. and Yang, X.J. (2006) Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 113, 2229-2237. 
doi:10.1161/CIRCULATIONAHA.105.583039</mixed-citation></ref><ref id="scirp.29930-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Capi, O. and Gepstein, L. (2006) Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Journal of Controlled Release, 116, 211-218. doi:10.1016/j. jconrel.2006.06.027</mixed-citation></ref><ref id="scirp.29930-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Cheng, M., Park, H., Engelmayr, G.C., Moretti, M. and Freed, L.E. (2007) Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Engineering, 13, 2709-2719. doi:10.1089/ ten.2006.0414</mixed-citation></ref><ref id="scirp.29930-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leor</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> Aboulafia-Etzion</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> Dar</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Shapiro</surname><given-names> L.</given-names></name>,<name name-style="western"><surname> Barbash</surname><given-names> I.M.</given-names></name>,<name name-style="western"><surname> Battler</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Granot</surname><given-names> Y. and Cohen</given-names></name>,<name name-style="western"><surname> S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium</article-title><source> Circulation</source><volume> 102</volume>,<fpage> 56</fpage>-<lpage>61</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.29930-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ishii, O., Shin, M., Sueda, T. and Vacanti, J.P. (2005) In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. The Journal of Thoracic and Cardiovascular Surgery, 130, 1358-1363. doi:10.1016/j.jtcvs.2005.05.048</mixed-citation></ref><ref id="scirp.29930-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Courtman, D.W., Pereira, C.A., Kashef, V., McComb, D., Lee, J.M. and Wilson, G.J. (1994) Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. Journal of Biomedical Materials Research, 28, 655-666. 
doi:10.1002/jbm.820280602</mixed-citation></ref><ref id="scirp.29930-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mirensky, T.L. and Breuer, C.K. (2008) The development of tissue-engineered grafts for reconstructive cardiotho racic surgical applications. Pediatric Research, 63, 559-568. doi:10.1203/01.pdr.0000305938.92695.b9</mixed-citation></ref><ref id="scirp.29930-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ge, D., Liu, X., Li, L., Wu, J., Tu, Q., Shi, Y. and Chen, H. (2009) Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochemical and Biophysical Research Communications, 381, 317-321. 
doi:10.1016/j.bbrc.2009.01.173</mixed-citation></ref><ref id="scirp.29930-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Yuasa, S. and Fukuda, K. (2008) Cardiac regenerative medicine. Circulation Journal, 72, 49-55. 
doi:10.1253/circj.CJ-08-0378</mixed-citation></ref><ref id="scirp.29930-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. and Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147. doi:10.1126/science.284.5411.143</mixed-citation></ref><ref id="scirp.29930-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Psaltis, P.J., Zannettino, A.C., Worthley, S.G. and Gronthos, S. (2008) Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells, 26, 2201-2210. doi:10.1634/stemcells.2008-0428</mixed-citation></ref><ref id="scirp.29930-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.G. and Prockop, D.J. (2002) Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells, 20, 530-541. 
doi:10.1634/stemcells.20-6-530</mixed-citation></ref><ref id="scirp.29930-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Qian, H.Y. (2007) Experimental study of cardiomyocyte differentiation from porcine bone marrow mesenchymal stem cell in vitro and optimized transplantation to treat acute myocardial infarction in vivo. Ph.D. Thesis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.</mixed-citation></ref><ref id="scirp.29930-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Yoon, J., Shim, W.J., Ro, Y.M. and Lim, D.S. (2005) Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Annals of Hematology, 84, 715-721.  
doi:10.1007/s00277-005-1068-7</mixed-citation></ref><ref id="scirp.29930-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Akhyari, P., Kamiya, H., Haverich, A., Karck, M. and Lichtenberg, A. (2008) Myocardial tissue engineering: The extracellular matrix. European Journal Cardio-Thoracic Surgery, 34, 229-241. 
doi:10.1016/j.ejcts.2008.03.062</mixed-citation></ref><ref id="scirp.29930-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Kanematsu, A., Yamamoto, S., Ozeki, M., Noguchi, T., Kanatani, I., Ogawa, O. and Tabata, Y. (2004) Collagenous matrices as release carriers of exogenous growth factors. Biomaterials, 25, 4513-4320. 
doi:10.1016/j.biomaterials.2003.11.035</mixed-citation></ref><ref id="scirp.29930-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Chang, Y., Tsai, C.C., Liang, H.C. and Sung, H.W. (2002) In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials, 23, 2447-2457. 
doi:10.1016/S0142-9612(01)00379-9</mixed-citation></ref><ref id="scirp.29930-ref28"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names> S. and Li</given-names></name>,<name name-style="western"><surname> W.-B. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>Current situation and prospect in the study of acellular tissue engineering heart valve</article-title><source> China Medical Device Information</source><volume> 15</volume>,<fpage> 13</fpage>-<lpage>21</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.29930-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Salacinski, H. J., Tiwari, A., Hamilton, G. and Seifalian, A.M. (2001) Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Medical &amp; Biological Engineering &amp; Computing, 39, 609-618. doi:10.1007/BF02345431</mixed-citation></ref></ref-list></back></article>